People In The News

NEW YORK (GenomeWeb News) – 23andMe Co-founder Linda Avey has left the personal genomics services company to start a foundation that will focus on Alzheimer's disease. The foundation Avey will run will use the 23andMe research platform to search for causes of and treatments for the disease.

Avey's departure was effective as of Sept. 4, the day the announcement was made.

Avey and co-founder Anne Wojcicki started the company together around three years ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.